Learn our city’s data and spread the word!
Philadelphia is one of very few sites around the country with enhanced hepatitis surveillance capacity.
Check out the latest case counts and data trends of the hepatitis epidemic in our city at the Philadelphia Department of Public Health’s:
The Philadelphia Department of Public Health releases an annual report covering data on all reportable conditions. Look at disease trends and mapped surveillance data about Hepatitis and more.
Philadelphia Department of Public Health Annual Reports
About: HepVu is an interactive online resource that visualizes the first standardized state-level estimates of people with past or current Hepatitis C infection across the United States. These estimates were generated by Emory University’s Coalition for Applied Modeling for Prevention (CAMP), a project supported by the Centers for Disease Control and Prevention (CDC).
Access this tool at https://hepvu.org/
Who We Are
HepVu is a Powered By AIDSVu project presented by the Rollins School of Public Health at Emory University in partnership with Gilead Sciences, Inc.
State-level Hepatitis C antibody prevalence estimates were derived from an Emory University Coalition for Applied Modeling for Prevention (CAMP) modeling project, “Estimation of State-level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010,” which was published in the peer-reviewed journal Clinical Infectious Diseases.
The development of HepVu was guided by the following group of viral hepatitis experts:
Ronald Valdiserri, MD, MPH Senior Research Associate, Johns Hopkins University
Timothy M. Block, Professor, Co‐Founder and President, Hepatitis B Foundation and Baruch S. Blumberg Institute
Ryan Clary, Executive Director, The National Viral Hepatitis Roundtable
Dawn Fishbein, MD, Scientific Director, Viral Hepatitis Research, MedStar Health Research Institute
Jim Galbraith, MD Associate Professor, UAB Emergency Medicine Department
Charles Howell, MD Chair of Medicine, Howard University Hospital
Gregorio Millett, Vice President and Director, Public Policy, amfAR
Shauna Onofrey, Viral Hepatitis Surveillance Coordinator, Massachusetts Department of Health
Murray Penner, Executive Director, NASTAD
Alexandra Shirreffs, Viral Hepatitis Prevention Coordinator, Philadelphia Health Department
John Ward, MD, Director, Viral Hepatitis Program, Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
Powered By AIDSVu projects use the existing AIDSVu.org infrastructure to help visualize complex data from other projects to inform public health.
The CDC has a national campaign to increase awareness and testing for hepatitis. Find videos, posters and data to support your efforts at
https://www.cdc.gov/knowmorehepatitis/index.htm
The World Health Organization declared global elimination goals of hepatitis by 2030. Learn about the international strategy, understand the goals, adopt the framework, download tools to implement, access customize-able campaign materials.
The National Academies of Sciences Engineering and Medicine has developed a two phase report to first access the national hepatitis epidemic, and second outline a strategy for elimination.
Read the report HERE
Mission
The National Viral Hepatitis Roundtable is a broad coalition working to fight, and ultimately end, the hepatitis B and hepatitis C epidemics. We seek an aggressive response from policymakers, public health officials, medical and health care providers, the media, and the general public through our advocacy, education, and technical assistance.
Vision
NVHR believes an end to the hepatitis B and C epidemics is within our reach and can be achieved through addressing stigma and health disparities, removing barriers to prevention, care and treatment, and ensuring respect and compassion for all affected communities.
Join the national effort http://nvhr.org/
Hepatitis Appropriations Partnership
NASTAD convenes the Hepatitis Appropriations Partnership (HAP), a national coalition based in Washington, D.C. that includes community-based organizations, public health and provider associations, national hepatitis and HIV organizations and diagnostic, pharmaceutical and biotechnology companies from all over the country. HAP works with federal policy makers in Congress and the Executive branch and with public health officials to increase federal support and funding for hepatitis prevention, testing, education, research, surveillance, and treatment.
Learn more HERE
Hepatitis Appropriations Partnership
NASTAD convenes the Hepatitis Appropriations Partnership (HAP), a national coalition based in Washington, D.C. that includes community-based organizations, public health and provider associations, national hepatitis and HIV organizations and diagnostic, pharmaceutical and biotechnology companies from all over the country. HAP works with federal policy makers in Congress and the Executive branch and with public health officials to increase federal support and funding for hepatitis prevention, testing, education, research, surveillance, and treatment.
Learn more HERE